X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

PMN

Closed

Promis Neurosciences Inc.

0.4887
+0.0087 (+1.81%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.48
Day's Range: 0.4802 - 0.495
Send
When Written:
 
4.72
ProMIS Neurosciences Inc. is a biotechnology company based in Toronto, Canada. The company is focused on developing precision medicine therapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and ALS (amyotrophic lateral sclerosis). ProMIS Neurosciences uses its proprietary discovery platform to identify and develop antibody therapeutics that selectively target toxic oligomers and misfolded proteins associated with neurodegenerative diseases. The company's lead product candidate is PMN310, a monoclonal antibody that targets toxic oligomers of amyloid beta, a protein that is believed to play a key role in the development of Alzheimer's disease. ProMIS Neurosciences was founded in 2004 and went public in 2015.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X